Literature DB >> 20425782

Animal models of Williams syndrome.

Lucy R Osborne1.   

Abstract

In recent years, researchers have generated a variety of mouse models in an attempt to dissect the contribution of individual genes to the complex phenotype associated with Williams syndrome (WS). The mouse genome is easily manipulated to produce animals that are copies of humans with genetic conditions, be it with null mutations, hypomorphic mutations, point mutations, or even large deletions encompassing many genes. The existing mouse models certainly seem to implicate hemizygosity for ELN, BAZ1B, CLIP2, and GTF2IRD1 in WS, and new mice with large deletions of the WS region are helping us to understand both the additive and potential combinatorial effects of hemizygosity for specific genes. However, not all genes that are haploinsufficient in humans prove to be so in mice and the effect of genetic background can also have a significant effect on the penetrance of many phenotypes. Thus although mouse models are powerful tools, the information garnered from their study must be carefully interpreted. Nevertheless, mouse models look set to provide a wealth of information about the neuroanatomy, neurophysiology and molecular pathways that underlie WS and in the future will act as essential tools for the development and testing of therapeutics.

Entities:  

Mesh:

Year:  2010        PMID: 20425782      PMCID: PMC2894081          DOI: 10.1002/ajmg.c.30257

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  60 in total

1.  Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.

Authors:  M E Durkin; C L Keck-Waggoner; N C Popescu; S S Thorgeirsson
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

2.  Discriminating power of localized three-dimensional facial morphology.

Authors:  Peter Hammond; Tim J Hutton; Judith E Allanson; Bernard Buxton; Linda E Campbell; Jill Clayton-Smith; Dian Donnai; Annette Karmiloff-Smith; Kay Metcalfe; Kieran C Murphy; Michael Patton; Barbara Pober; Katrina Prescott; Pete Scambler; Adam Shaw; Ann C M Smith; Angela F Stevens; I Karen Temple; Raoul Hennekam; May Tassabehji
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

3.  Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1.

Authors:  Tanisha A Jackson; Harry E Taylor; Deva Sharma; Stephen Desiderio; Sonye K Danoff
Journal:  J Biol Chem       Date:  2005-06-07       Impact factor: 5.157

4.  Frizzled 9 knock-out mice have abnormal B-cell development.

Authors:  Erik A Ranheim; Helen C K Kwan; Tannishtha Reya; Yu-Ker Wang; Irving L Weissman; Uta Francke
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

5.  Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.

Authors:  Stephen J Palmer; Nicole Santucci; Jocelyn Widagdo; Sara J Bontempo; Kylie M Taylor; Enoch S E Tay; Jeff Hook; Frances Lemckert; Peter W Gunning; Edna C Hardeman
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

6.  GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.

Authors:  Colleen A Morris; Carolyn B Mervis; Holly H Hobart; Ronald G Gregg; Jacquelyn Bertrand; Gregory J Ensing; Annemarie Sommer; Cynthia A Moore; Robert J Hopkin; Patricia A Spallone; Mark T Keating; Lucy Osborne; Kendra W Kimberley; A Dean Stock
Journal:  Am J Med Genet A       Date:  2003-11-15       Impact factor: 2.802

7.  New findings concerning cardiovascular manifestations emerging from long-term follow-up of 150 patients with the Williams-Beuren-Beuren syndrome.

Authors:  Alessia Del Pasqua; Gabriele Rinelli; Alessandra Toscano; Roberta Iacobelli; Cristina Digilio; Bruno Marino; Claudia Saffirio; Sergio Mondillo; Luciano Pasquini; Stephen Pruett Sanders; Andrea de Zorzi
Journal:  Cardiol Young       Date:  2009-12       Impact factor: 1.093

Review 8.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice.

Authors:  A Holmes; C C Wrenn; A P Harris; K E Thayer; J N Crawley
Journal:  Genes Brain Behav       Date:  2002-01       Impact factor: 3.449

Review 9.  ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.

Authors:  Katsumi Iizuka; Yukio Horikawa
Journal:  Endocr J       Date:  2008-05-19       Impact factor: 2.349

10.  Novel arterial pathology in mice and humans hemizygous for elastin.

Authors:  D Y Li; G Faury; D G Taylor; E C Davis; W A Boyle; R P Mecham; P Stenzel; B Boak; M T Keating
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

View more
  27 in total

1.  The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

Authors:  Paulina Carmona-Mora; Jocelyn Widagdo; Florence Tomasetig; Cesar P Canales; Yeojoon Cha; Wei Lee; Abdullah Alshawaf; Mirella Dottori; Renee M Whan; Edna C Hardeman; Stephen J Palmer
Journal:  Hum Genet       Date:  2015-08-15       Impact factor: 4.132

Review 2.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 3.  The roots of empathy: Through the lens of rodent models.

Authors:  K Z Meyza; I Ben-Ami Bartal; M H Monfils; J B Panksepp; E Knapska
Journal:  Neurosci Biobehav Rev       Date:  2016-11-04       Impact factor: 8.989

4.  The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.

Authors:  Geert Vandeweyer; Nathalie Van der Aa; Edwin Reyniers; R Frank Kooy
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

5.  Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.

Authors:  Nathan D Kopp; Kayla R Nygaard; Yating Liu; Katherine B McCullough; Susan E Maloney; Harrison W Gabel; Joseph D Dougherty
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

6.  Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.

Authors:  Nathan Kopp; Katherine McCullough; Susan E Maloney; Joseph D Dougherty
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

7.  Williams Syndrome Transcription Factor is critical for neural crest cell function in Xenopus laevis.

Authors:  Chris Barnett; Oya Yazgan; Hui-Ching Kuo; Sreepurna Malakar; Trevor Thomas; Amanda Fitzgerald; William Harbour; Jonathan J Henry; Jocelyn E Krebs
Journal:  Mech Dev       Date:  2012-06-09       Impact factor: 1.882

8.  Altered microstructure within social-cognitive brain networks during childhood in Williams syndrome.

Authors:  Brian W Haas; Naama Barnea-Goraly; Kristen E Sheau; Bun Yamagata; Shruti Ullas; Allan L Reiss
Journal:  Cereb Cortex       Date:  2013-05-24       Impact factor: 5.357

9.  Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.

Authors:  Caroline Kinnear; Wing Y Chang; Shahryar Khattak; Aleksander Hinek; Tadeo Thompson; Deivid de Carvalho Rodrigues; Karen Kennedy; Naila Mahmut; Peter Pasceri; William L Stanford; James Ellis; Seema Mital
Journal:  Stem Cells Transl Med       Date:  2012-12-21       Impact factor: 6.940

10.  Core transcriptional networks in Williams syndrome: IGF1-PI3K-AKT-mTOR, MAPK and actin signaling at the synapse echo autism.

Authors:  Li Dai; Robert B Weiss; Diane M Dunn; Anna Ramirez; Sharan Paul; Julie R Korenberg
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.